[ad_1]
Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.
Medscape Medical News
[ad_2]
Source link : https://www.medscape.com/viewarticle/induction-immunotherapy-has-durable-survival-benefit-locally-2026a1000lzq?src=rss
Author :
Publish date : 2026-06-29 11:58:00
Copyright for syndicated content belongs to the linked Source.